SCHEMBL17070211

SCHEMBL17070211

Fc1cccc(-c2ccc(C3CCCCCC3)cc2)c1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.50
ESR2 Q92731 1/20 0.50
PAX8 Q06710 3/20 0.44
HSP90AA1 P07900 1/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
CYP3A4 P08684 3/20 0.41
DHODH Q02127 1/20 0.41
CYP17A1 P05093 1/20 0.41
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
NOTUM Q6P988 1/20 0.41
PGR P06401 1/20 0.40
CYP2C9 P11712 1/20 0.40
APP P05067 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28563667 0.98 TAAR1 (0.52) TAAR1ESR2PAX8HSP90AA1GAA
SCHEMBL28548683 0.95 TAAR1 (0.52) TAAR1ESR2PAX8CYP3A4CYP17A1
SCHEMBL28560659 0.91 TAAR1 (0.55) TAAR1ESR2PAX8CYP3A4CYP17A1
SCHEMBL16887403 0.84 HSP90AA1 (0.47) HSP90AA1GAAMAPTKMT2ATDP1
SCHEMBL11764880 0.84 NPC1 (0.51) HSP90AA1GAAMAPTKMT2ATDP1
SCHEMBL10091176 0.83 TAAR1 (0.47) TAAR1ESR2PAX8CYP3A4CYP17A1
SCHEMBL16978438 0.82 HSP90AA1 (0.45) HSP90AA1GAAMAPTKMT2ATDP1
SCHEMBL15906653 0.81 NOTUM (0.47) PAX8HSP90AA1GAAMAPTKMT2A
SCHEMBL27830967 0.80 KMO (0.53) TAAR1GAAKMT2ACYP11B2
SCHEMBL130265 0.80 KMO (0.53) TAAR1GAAKMT2ACYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9493704-B2 Cycloheptane derivative and preparation method and use thereof SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) 2016-11-15 US disclosed
US-9493704-B2 Cycloheptane derivative and preparation method and use thereof SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) 2016-11-15 US disclosed
US-20150252261-A1 CYCLOHEPTANE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD (CN) 2015-09-10 US disclosed
US-20150252261-A1 CYCLOHEPTANE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD (CN) 2015-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150252261-A1 CYCLOHEPTANE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF DHPS, DHCR24, CCNT1 TAAR1 3786/4885ESR2 3520/4885PAX8 2764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.